Chronic treatment with infliximab does not affect insulin resistance or endothelial function in men with the metabolic syndrome - a placebo-controlled pilot trial

Verbundene Inhalte

• Publikationen

• Chronic treatment with infliximab does not affect insulin resistance or endothelial function in men with the metabolic syndrome - a placebo-controlled pilot trial

  Publikation: Beitrag in Fachzeitschrift › Konferenzabstract